About the Author

Mr. Ronald A. Rader has been President of his own publishing/consulting company, the Biotechnology Information Institute,
since late 1990. Mr. Rader has a B.S. (Microbiology), M.L.S. (Library/Info. Sci.), and over 35 years experience as a
biotechnology and pharmaceutical information specialist, author, publisher and consultant. He is a world-class expert in biotechnology and pharmaceutical information, competitive intelligence, technology and market assessments, and information resources development; and concerning biopharmaceutical products and industry [See his full Resume].

From 1985-1990, Mr. Rader was Manager of Information Services, Porton International plc, providing information and competitive intelligence services and market/technology analyses for what was then the world's largest privately-held biotechnology company. Prior to that he served as a biomedical/chemical information specialist/manager/analyst with companies including Gillette Medical Evaluation Labs., Gillette Co.; MITRE Corp.; Biospherics; Computer Sciences Corp. (CSC); Technical Resources Inc.; and Bio-Conversion Labs.

"How Big is the World Market for Biopharmaceuticals? It All Depends How You Define Biopharmaceutical," in Friedman, Y., Best Practices in Biotechnology Business Development, Logo Press, p. 175-85, 2008.

Survey of Compounds Which Have Been Tested for Carcinogenic Activity [Chemical Editor]

"Analysis of U.S. Biotechnology Patents," issued annually, 1986-1988, by the Pharmaceutical Manufacturers Association (PMA, now PhRMA).

Structure and Activity Search System (SANNS); Chemical Evaluation Search and Retrieval System (CESARS), Thermodynamics and other other user guides for component databases of the NIH/EPA Chemical Information System (NIH/EPA CIS).